Fact CheckerSign in

NCT06260228Active, not recruiting

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Parkinson's Disease (PD) The main questions it aims to answer are: 1. Can the current HOBSCOTCH program be adapted for people with PD? 2. Will people with PD experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program? Participants will be asked to: * attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PD sessions with a one-on-one certified HOBSCOTCH-PD coach * complete a brief clinical questionnaire about their diagnosis of PD * complete two questionnaires before and after the HOBSCOTCH-PD sessions about their quality of life and about memory and thinking processes * keep a short daily diary about their PD symptoms and use of the self-management strategies taught in the HOBSCOTCH-PD program * complete a brief Satisfaction Survey after the entire HOBSCOTCH-PD program

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
29 Jan 2024
Start date
5 Jan 2024
Primary completion date
26 Sept 2025
Lead sponsor
Dartmouth-Hitchcock Medical Center
NCT number
NCT06260228

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 5 Jan 2024 to the primary completion date, 26 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant visual impairment precluding reading or writing

Other

  • Cognitive dysfunction that precludes participation in giving informed consent
  • No reliable telephone or internet access

Who the study is looking for

  • Age 30 - 75 years
  • Diagnosis of Parkinson's Disease per participant's provider
  • Literate, English-speaking with grade 12 or equivalent in education
  • Self-reported cognitive/memory difficulties
  • Telephone and internet access

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dartmouth Hitchcock
Coordinator of this site? Confirm its status
LebanonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.